Literature DB >> 8437497

[Cardiocirculatory side effects of hyperthermic extremity perfusion].

G Omlor1, G Molter, S Meessen, G Gross, U Seyfert, G Feifel.   

Abstract

The risk of cardiocirculatory disorders was investigated in 23 consecutive patients with high-risk melanomas, who had been treated with hyperthermal limb perfusion. Postoperatively, there was a rise in the pulmonary vascular resistance. In addition, 14 patients with vascular occlusive diseases (1-2b, Fontaine) showed intraoperatively an increasing amount of leakage of the extracorporeal circulation. Elevations of thromboxane and prostacyclin in excess of the norm caused by mechanical and thermic traumatization of blood in the heart lung machine were detected in 8 patients investigated during and after the perfusion procedure. Significant increase of cisplatin, one of the two cytostatic agents injected extracorporeally, could not be demonstrated in the blood of the systemic circulation by atomic absorption spectroscopy. Increased pulmonary and arterial pressure disorders were observed in the group with occlusive vascular diseases, caused by a rising rate of vascular collaterals to the body and the rising rate of thromboxane and prostacyclin in the body blood flow. We believe that it is necessary to monitor pulmonary arterial pressure during isolated limb perfusion, especially in patients with vascular occlusive disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437497

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  12 in total

1.  Hyperthermic perfusion with chemotherapy for melanoma of the extremities.

Authors:  F Ghussen; I Krüger; R V Smalley; W Groth
Journal:  World J Surg       Date:  1989 Sep-Oct       Impact factor: 3.352

2.  Lucy Wortham James lecture. Regional perfusion. Current sophistication, what next?

Authors:  E T Krementz
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

3.  Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion.

Authors:  F Di Filippo; A Calabrò; D Giannarelli; S Carlini; F Cavaliere; F Moscarelli; R Cavaliere
Journal:  Cancer       Date:  1989-06-15       Impact factor: 6.860

4.  Isolation perfusion of the lower limb with platinum.

Authors:  M Vaglini; F Belli; M Santinami
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

5.  Hyperthermic isolation perfusion of the limbs with cytostatics after surgical excision of sarcomas.

Authors:  F J Lejeune; D Lienard; P Ewalenko
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

6.  Hyperthermic perfusion with chemotherapy for cancers of the extremities.

Authors:  J S Stehlin
Journal:  Surg Gynecol Obstet       Date:  1969-08

7.  Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities.

Authors:  M Santinami; F Belli; N Cascinelli; D Rovini; M Vaglini
Journal:  J Surg Oncol       Date:  1989-11       Impact factor: 3.454

8.  Clinical study of blood trauma during perfusion with membrane and bubble oxygenators.

Authors:  J J van den Dungen; G F Karliczek; U Brenken; J N Homan van der Heide; C R Wildevuur
Journal:  J Thorac Cardiovasc Surg       Date:  1982-01       Impact factor: 5.209

9.  [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].

Authors:  J Tonak; W Hohenberger; J Göhl
Journal:  Chirurg       Date:  1984-08       Impact factor: 0.955

10.  Isolated limb perfusion for stage I melanoma of the extremity: a comparison of melphalan and dacarbazine (DTIC).

Authors:  M J Edwards; A W Boddie; F C Ames; C M McBride
Journal:  South Med J       Date:  1989-08       Impact factor: 0.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.